Sarepta Therapeutics along with partner Roche presented new analyses and functional data from several studies evaluating SRP-9001 (rAAVrh74.MHCK7.micro-dystrophin), a gene transfer therapy for patients with…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.